Phase I Clinical Evaluation of Designed Ankyrin Repeat Protein [99mTc]Tc(CO)3-(HE)3-Ec1 for Visualization of EpCAM-Expressing Lung Cancer. [PDF]
Zelchan R +15 more
europepmc +1 more source
Figure 4 tabular data for the paper Development of LRRK2 designed ankyrin-repeat proteins
Eva Karasmanis +7 more
openalex +1 more source
Functional Activity and Binding Specificity of Small Ankyrin Repeat Proteins Called Ankyrons Against SARS-CoV-2 Variants [PDF]
Yun-Jong Park +6 more
openalex +1 more source
ArfGAP with the SH3 Domain, Ankyrin Repeat and PH Domain 1 Inversely Regulates Programmed Death-Ligand 1 Through Negative Feedback of Phosphorylated Epithelial Growth Factor Receptor and Activation of Nuclear Factor-Kappa B in Non-Small Cell Lung Cancer. [PDF]
Chiba N +8 more
europepmc +1 more source
The Designed Ankyrin Repeat Protein Antiviral Ensovibep for Nonhospitalized Patients With Coronavirus Disease 2019: Results From EMPATHY, a Randomized, Placebo-Controlled Phase 2 Study. [PDF]
Kingsley J +22 more
europepmc +1 more source
Thermostable designed ankyrin repeat proteins (DARPins) as building blocks for innovative drugs
Schilling J +8 more
europepmc +1 more source
Preclinical evaluation of EpCAM-binding designed ankyrin repeat proteins (DARPins) as targeting moieties for bimodal near-infrared fluorescence and photoacoustic imaging of cancer. [PDF]
Houvast RD +14 more
europepmc +1 more source

